Closed BorisUitham closed 1 year ago
Since last week, + 1 sequence from Vorarlberg, Austria and +1 from Midtjylland, Denmark. Curiously, the sequence from Denmark also has I844V, another very rare mutation (2236 sequences as of today) and in close proximity to 839N
I'm pretty sure these two CH.1.1 uploaded from Germany belong to this lineage, but a lot of labs in Germany seem unable to sequence S:681, so no mutation is registered there on either. EPI_ISL_16597614, EPI_ISL_16597640
Thank you, nextclade also assigns them CH.1.1.4 so it does seem that way. Edit: A hack-y way to catch all current 41 cases without searching for 681r could be: Spike_D839N, Spike_F486S, T23773C
I count 55 on GISAID. Two more from croatia and germany also have s:844v
The cov-Spectrum shows that there are now 51 sequences(Spike_P681R,Spike_D839N,Spike_F486S), maybe it updates a little slower than GISAID
It now has 53 sequences according to the cov-spectrum
56 sequences now
From the current point of view, up to 96% of the newly added CH.1.1.4 samples in the recent month contain D839N. Maybe there should be a discussion on whether to include D839N in the definition mutation of CH.1.1.4 and whether to name CH.1.1.4.1 ——(CH.1.1.4+D839N) @corneliusroemer @BorisUitham
59 sequences now @BorisUitham Maybe this issue should be updated
CH.1.1.4 doesn't really go anywhere, still only ~100 sequences worldwide, and this sublineage isn't much different. Will close for now.
Description: Sub-lineage of CH.1.1.4 with S:D839N Earliest sequence: 2022-11-14 Most recent sequence: 2023-01-12 Countries circulating: Austria (38 sequences): 34 Vorarlberg, 3 Tyrol, 1 Lower Austria. Denmark (1 sequence): 1 Midtjylland. Germany (2 sequences): 2 Baden-Württemberg GISAID query: Spike_P681R, Spike_D839N, Spike_F486S
Genomes EPI_ISL_15915165, EPI_ISL_15995866, EPI_ISL_16064877, EPI_ISL_16064888, EPI_ISL_16064938, EPI_ISL_16164357, EPI_ISL_16164369, EPI_ISL_16164466, EPI_ISL_16164533, EPI_ISL_16164581, EPI_ISL_16164711, EPI_ISL_16243487, EPI_ISL_16262625, EPI_ISL_16263657, EPI_ISL_16263679, EPI_ISL_16263693, EPI_ISL_16263749, EPI_ISL_16263756, EPI_ISL_16420466, EPI_ISL_16421634, EPI_ISL_16421638, EPI_ISL_16421662, EPI_ISL_16421665, EPI_ISL_16421667, EPI_ISL_16421678, EPI_ISL_16421688-16421689, EPI_ISL_16421698, EPI_ISL_16421714, EPI_ISL_16421728, EPI_ISL_16421745, EPI_ISL_16421752
Usher Tree Only one sample is fully sequenced and able to be placed in a phylogenetic tree. This shows the relation to CH.1.1.4.
Covspectrum query: https://cov-spectrum.org/explore/World/AllSamples/Past6M/variants?aaMutations=s%3Ad839n%2Cs%3Ap681r&nextcladePangoLineage=ch.1.1*&
Growth advantage: The recently designated CH.1.1.4 (when excluding samples with d839n) seems to be at a growth disadvantage and has not spread much. However, when comparing CH.1.1.4 + D839N with a baseline of CH.1.1, there is an advantage of 53% (22-83) over ch.1.1 in austria. In vorarlberg alone, this is 68% (31-104) and predicts 68% of CH.1.1 samples on 09-01 to be CH.1.1.4 + D839N. For comparison, CH.1.1.4 minus D839N has a calculated advantage over ch.1.1 of -12 (-23 - 0) in austria and -7 (-20 - 5) in vorarlberg. Thus the growth advantage over CH.1.1. When looking at growth advantage over current variant mix, this is 78% (46 - 111) in austria and 85% (51 - 119) in vorarlberg. This would predict a prevalence of 26.07% (10.98 - 41.17) in vorarlberg on 09-01-2023, although i'm not certain on how accurate this is. Since “pure” CH.1.1.4 is not growing much anymore and yet this added mutation is, I would like to propose this as a further sublineage.
Sidenotes: D839N is a rare mutation, only being found in 909 samples since start of pandemic. Interestingly, most of these were during delta where a p681r was present as there is now: 69.70% of d839n in the 909 samples were with p681r. However even during delta this combo was only max 0.02% of all samples. Could it be that 681r allows for a stable 839n?
According to the following source from 2021, 839N might reduce fusogenicity. Extrapolation to omicron background is unknown. Barrett CT, Neal HE, Edmonds K, Moncman CL, Thompson R, Branttie JM, Boggs KB, Wu C-Y, Leung DW, Dutch RE (2021) Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion. J Biol Chem 297:100902